In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells. - Srinivasulu Cheemanapalli; Chandrasekaran Palaniappan; Yeshwanth Mahesh; Yuvaraj Iyyappan; Suresh Yarrappagaari; Kanagaraj Sekar (Comput. Biol. Medicine, 2023)